GlassScriptPhysician profile
Waseem Sajjad
NPI 1891913232
$11,917.77
in general payments reported to CMS, 2019-2025
31 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,330 · 2020: $190 · 2021: $2,197 · 2022: $5,829 · 2023: $956 · 2024: $19.67 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079 · Travel and Lodging: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.34 |
| Travel and Lodging | $292.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,108.26 | 2021-2022 | |
| Abbott Laboratories | $2,535.69 | 2021-2023 | Mitraclip |
| Medtronic Vascular, INC. | $1,449.16 | 2019 | |
| Edwards Lifesciences Corporation | $1,231.34 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $630.95 | 2019-2025 | Opticross, Cds - Mct/Cem Monitoring, Watchman Flx |
| Janssen Research & Development, LLC | $582.08 | 2023 | |
| Biosense Webster, INC. | $259.87 | 2019-2022 | |
| Medical Device Business Services, INC. | $235.23 | 2019 | |
| Philips North America LLC | $219.14 | 2019-2021 | |
| Abiomed | $213.14 | 2020-2025 | |
| Amgen INC. | $200.88 | 2019-2025 | Repatha |
| Asahi Intecc USA, INC. | $192.03 | 2021-2022 | |
| Endologix LLC | $142.95 | 2021 | |
| W. L. Gore & Associates, INC. | $138.47 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $129.32 | 2023 | Camzyos |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $108.50 | 2021 | |
| Janssen Pharmaceuticals, INC | $97.01 | 2019-2022 | |
| Biotronik INC. | $62.72 | 2019 | |
| Shockwave Medical, INC | $57.12 | 2025 | |
| Pfizer INC. | $54.97 | 2019-2021 | |
| Inari Medical, INC. | $42.29 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $41.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.81 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $21.81 | 2019 | |
| Alnylam Pharmaceuticals INC. | $21.43 | 2019 | |
| Penumbra, INC. | $20.97 | 2020 | |
| Bardy Diagnostics, INC. | $19.54 | 2020 | |
| Amarin Pharma, INC. | $18.59 | 2019 | |
| Astellas Pharma US INC | $17.36 | 2019 | |
| Merck Sharp & Dohme LLC | $15.78 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waseem Sajjad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.